OMNIPAQUE - iohexol

Omnipaque: compared with HOCM

	reduces adverse events[6-7,28] – less nausea and vomiting[29-30] – fewer skin reactions[30] reduces haemodynamic deterioration[31] – less change in erythrocyte morphology[32] – less impact on blood pressure[29,31] – less impact on heart rate[29,31]
	reduces electrocardiographic effects[33,34] reduces cardiac end-diastolic pressures[35] reduces the incidence of contrast-induced nephropathy[36]
	patient comfort[37] – marked improvement in heat sensation[35] – signiﬁcantly less pain[39] – signiﬁcantly less movement[39]